Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,977,506,192
+$448,856,650 QoQ
Shares Held
15,661,323
+8.5% QoQ
Ownership
0.650%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#22
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 40%
Shared 1%
None 59%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2020CallValue
$63,466
CallShares
484
PutValue
$23,340
PutShares
178
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $18,000,750,668 across 17 Drug Manufacturers - General names. JNJ ranks #2 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,379,627 | $4,053,626,340 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
15,661,323 | $3,977,506,192 | |
| 3 | ABBV |
AbbVie Inc.
|
10,772,949 | $2,710,904,874 | |
| 4 | AZN |
Astrazeneca PLC
|
12,640,672 | $2,396,924,218 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,964,180 | $1,537,397,125 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,269,170 | $918,386,928 | |
| 7 | AMGN |
Amgen Inc
|
2,355,705 | $853,047,884 | |
| 8 | PFE |
Pfizer Inc
|
31,492,018 | $758,327,787 |
All Filings in JNJ
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,977,506,192 | 15,661,323 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $3,528,649,542 | 14,435,647 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,792,617,644 | 13,494,166 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,575,227,540 | 13,888,618 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,420,419,363 | 15,845,626 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,536,998,086 | 15,297,866 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,004,449,532 | 13,860,113 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $2,311,507,960 | 14,263,285 | Shares | Sole | 2025-06-26 | |
| 2024-06-30 | $2,154,838,334 | 14,743,010 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $2,230,362,720 | 14,099,265 | Shares | Sole | 2025-06-02 | |
| 2023-12-31 | $2,027,474,682 | 12,935,273 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,877,189,799 | 12,052,583 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $2,375,934,650 | 14,354,366 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,363,934,605 | 15,251,191 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,691,822,015 | 15,238,166 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,526,447,665 | 15,465,522 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,721,250,301 | 15,330,124 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,727,579,968 | 15,390,058 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,944,900,416 | 17,214,593 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,643,097,852 | 16,365,931 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $2,674,456,529 | 16,234,409 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,568,729,354 | 15,629,628 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,419,635,178 | 15,374,477 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,232,684,717 | 14,996,539 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,987,780,432 | 14,134,825 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,865,391,773 | 14,225,515 | Shares | Defined | 2020-05-14 | |
| 2020-03-31 | $23,340 | 178 | Put | Defined | 2020-05-14 | |
| 2020-03-31 | $63,466 | 484 | Call | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||